[Gynaecological use of prolactin inhibitor bromocriptin (author's transl)].
Bromocriptinee has proved to be effective in treatment of patients for hyperprolactinaemic diseases. The authors suggest that in gynaecology it should be used, first of all, in treating patients for hyperprolactinaemic sterility and galactorrhoea and, in extraordinary cases, for postpartum inhibition of lactation. Bromocriptin should be prescribed only at endocrinological institutions with facilities for follow-up control by serum prolactin assay.
D000568:Amenorrhea / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use*; D004412:Dysmenorrhea / Q000188:drug therapy; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007774:Lactation / Q000187:drug effects; D011247:Pregnancy
D001971:Bromocriptine
Die Anwendung des Prolaktinhemmers Bromocriptine in der Frauenheilkunde.